BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Teva Pharmaceutical Industries Limited 

5 Basel Street

Petach Tikva    49131  Israel
Phone: 972-3-9267-267 Fax: 972-3-9234-050


SEARCH JOBS




Industry
Biotechnology






 Company News
BioSpace (DHX) Temperature Poll: Will Mylan (MYL) Buy Teva (TEVA), As Predator Becomes Prey? 5/19/2015 10:00:29 AM
Teva (TEVA)To Present New Respiratory Data At 2015 Annual International Meeting Of The American Thoracic Society 5/15/2015 11:30:58 AM
Teva (TEVA) Presents Further Data From Phase IIb With TEV-48125 In Chronic Migraine At The International Headache Society Congress (IHC): Efficacy And Safety Results At All Doses And Endpoints Present Robust Case For Progression To Phase III 5/14/2015 11:09:12 AM
Mylan (MYL) Chairman Tells Investors He Would Consider Buying Rival Teva (TEVA) 5/11/2015 7:15:00 AM
Teva (TEVA) Completes Acquisition Of Auspex Pharmaceuticals (ASPX) 5/5/2015 8:47:30 AM
Teva (TEVA) Reports First Quarter 2015 Results 4/30/2015 1:27:26 PM
Teva (TEVA) Sends Letter To Mylan (MYL) Board 4/30/2015 1:21:25 PM
Teva (TEVA) Launches Generic Abilify Tablets In The United States 4/29/2015 9:59:02 AM
Teva (TEVA) Continues To Invigorate Injectable Portfolio With The Launch Of Argatroban Injection In The United States 4/28/2015 8:51:24 AM
Teva (TEVA) Reiterates Commitment To Cash-And-Stock Acquisition Of Mylan (MYL) For $82.00 Per Share 4/27/2015 8:44:35 AM
12345678910...